Seroprevalence of hepatitis D virus among blood donors with hepatitis B surface antigen at Yaounde Central Hospital, Cameroon Background and Objectives Hepatitis delta virus (HDV) superinfection with hepatitis B virus (HBV) infection can cause a severe form of viral hepatitis. A nation-wide general population study in Came...

Findings underscore the importance of continued HBV prevention, including vaccination, to protect blood donors and the wider community.

onlinelibrary.wiley.com/doi/abs/10.1...

#BloodSafety #HepatitisD #HBV #GlobalHealth #Research #Cameroon

China clears its first drug for chronic hepatitis D Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus.

#HuahuiHealth has won the #firstapproval in #China for a drug to treat chronic infections with #hepatitisD virus (HDV), plugging a major gap in treatment options.

GastroAGI - AI Chat for Gastroenterology Students Ask AI-powered questions about gastroenterology and enhance your academic learning.

AASLD 2025 SOLSTICE Ph2: Tobevibart ± elebsiran in chronic #HepatitisD. Wk48 undetectable HDV RNA: 66% combo vs 48% mono; HBsAg <10 IU/mL: 91% vs 21%. Safe, well tolerated, no ALT flares. Promising dual HBV/HDV targeting.

🧠 gastroagi.com/chat

🎙️ Live now! Prof. Eui-Cheol Shin (KAIST, Korea) is presenting “Cytokine-induced bystander CD8+ T cell activation and its regulation in viral hepatitis” – part of our Translational Seminar Series.
Join the discussion live 👉 msteams.link/DGTP
#HepatitisD #D-SOLVE #HaDEA #EUHealth

Treatment response to #Bulevirtide is linked to amelioration of #PortalHypertension in patients with chronic #HepatitisD

JHEP Reports
www.jhep-reports.eu/article/S258...

🧬 D-SOLVE lecture via MS Teams:
Hepatitis D in Mongolia – Screening Study among Mongol Migrants in Sweden
👤 Speakers from Karolinska/Sweden & Mongolia
🗓️ Tue, 23 Sept | 🕐 12:45–13:30 CET
🔗 bit.ly/46oxjnH
🔑 ID: 368 532 223 585 | PW: dq64Nb9t
#DSOLVE #HepatitisD #PublicHealth

Bluejay begins phase 3 trial of brelovitug for hepatitis D - PharmaTimes First patient enrolled in AZURE-2 study comparing brelovitug to Hepcludex

#Bluejay #BluejayTherapeutics #phase3trial #brelovitug #BJT778 #hepatitisD #AZURE2study #CHD #hepatitisDvirus #cirrhosis #livercancer #viralhepatitis #liverdisease #BreakthroughTherapydesignation #FDA #PRIMEdesignation #Orphanstatus #OrphanDrug #EMA
pharmatimes.com/news/bluejay...

Flyer International HBV Meeting 8-12 Sept 2025 Berlin

🧬 Join the HBV Community Forum & Int. HBV Meeting in Berlin (Sept 8–12), on-site or online!
🎤 Science meets community – Hepatitis B & D!
D-SOLVE’s Heiner Wedemeyer & Helenie Kefalakes will be there.
👉 www.hbvmeeting.org
#HBVForum2025 #HepatitisB #HepatitisD

#HepatitisD carcinogenic

VIROMARKERS aims for revolution in care of people with persistent viral infections The new project is advancing biomarkers that would improve the care of people living with HIV and hepatitis D, plus stem cell transplant patients at risk of cytomegalovirus (CMV).

🌍 On #WorldHepatitisDay, discover how our @viromarkers.bsky.social project is advancing markers to predict which patients will respond best to new #HepatitisD drug #bulevirtide.
👉 europa.eu/!FfGjJN
#hepatitis #IHITransformingHealth #HorizonEU

TherVacB & D-Solve unterstützen den Welt-Hepatitis-Tag 2025 mit ihrer Kampagne „Aufklärung über HDV und HBV“ Gut informiert, besser geschützt mit unserer Kampagne „Aufklärung über HDV und HBV“ - alles, was Sie über Hepatitis D und B wissen sollten

💡 Sie suchen fundierte Informationen zu #HepatitisB & #HepatitisD?
Die Kampagne „Aufklärung zu #HDV & #HBV“ von #TherVacB & #DSOLVE erklärt Co-Infektion, Diagnose und Therapie in Videos mit Expertinnen & Patientenperspektiven⚕️

📺 Zur Videoreihe: tinyurl.com/HepatitisBDW...

#WHT2025 #HepSky

World Hepatitis Day 2025 with Ongoing Awareness Campaign “Insights on HDV and HBV” Stay informed, stay protected with our campaign “Insights on HDV and HBV” – everything you need to know about hepatitis D and B.

💡 Looking for trusted info on #HepatitisB & #HepatitisD?

The #TherVacB & #DSOLVE video campaign “Insights on #HDV & #HBV” explains co-infection, diagnosis & treatment in expert-led, patient-focused videos⚕️

📺 Explore the full resource: tinyurl.com/HepatitisBDInsights

#WHD2025 #LiverSky

Let’s Talk Hepatitis D!
Many people living with Hepatitis D (HDV) remain undiagnosed—but early detection can change lives. 💪

🩺 Screening. Diagnosis. Therapy.
Early diagnosis is the key to managing HDV

#HepatitisD #LiverHealth #ScreenForLife #HepBShot #HepatitisAwareness #LinkToCare #WorldHepatitis

A call to reclassify the delta hepatitis virus as an orphan ... : Hepatology Communications An abstract is unavailable.

Delta hepatitis (HDV) is deadly, neglected, and underfunded.

Our new article calls for HDV to be reclassified as an orphan disease—a key move to drive research, drug development & awareness. It’s time 🦠📣

🔗 journals.lww.com/hepcomm/page...
#HepatitisD #OrphanDisease #LiverHealth #GlobalHealth

Better insights into the hepatitis D virus Hannover researchers develop stem cell-based infection model

Significant findings for our #D-SOLVE project: Scientists from #TWINCORE developed a stem cell-based model for the #HepatitisD virus, revealing the transcription factor IRF1 as a target for new treatments, also in association with Hepcludex. More info: twincore.de/news/better-...

Anyone seeing reports of patients with #HepatitisD in the absence of #HepatitisB? My team is detecting #HDV antigens and RNA in salivary glands of #Sjogrens patients without evidence of #HBV. Thinking its more widespread. Current testing guidelines would miss. #ViroSky #LiverSky #GastroSky

🎬 Just Released! 🌍 Dive into our latest #HDV-Awareness - campaign video featuring Dr. Lisa Sandmann & Dr. Helenie Kefalakes (both #HannoverMedicalSchool & #D-SOLVE). Discover the "Standard of Treatment in Germany and Worldwide". Watch now! youtu.be/d7dV2G6tMXA #HepatitisD #LiverHealth

New #Feed: #HDV #HepD #HepatitisD #HepatitisDVirus #HDV-like #Kolmioviridae #HepDVirus Tracking the latest in HDV and HDV-like viruses, from new publications to scientific breakthroughs and global events. Exploring virology, epidemiology, treatments, and diagnostics.

bsky.app/profile/did:...

📢 New Video! Join Prof. Wedemeyer (Hannover Medical School, #D-SOLVE) as he discusses the symptoms & consequences of untreated #HepatitisD. This video is part of our #Awareness campaign, highlighting the importance of early detection and treatment. Watch now and stay informed! youtu.be/BLnRhVehOlE

In a phase 2b trial, 180 patients were assigned to receive peginterferon alone or combined with bulevirtide for chronic hepatitis D. Combo therapy showed promise for finite treatment. #HepatitisD #clinicaltrials PMID:38842520, N Engl J Med 2024

nChroma Bio Raises $75M to Advance Epigenetic Editing for Hepatitis B and D Cure The development of CRMA-1001, a potential functional cure for chronic hepatitis B and D, is set to enter clinical trials in 2025.

nChroma Bio raises $75M to advance CRMA-1001, a liver-targeted epigenetic therapy for chronic hepatitis B and D, with clinical trials set for 2025. #HepatitisB #HepatitisD #MEDsky #IDsky
Read more: www.contagionlive.com/view/nchroma...

Infos zu #HepatitisD (#HDV) und dem Medikament: www.klinikum.uni-heidelberg.de/newsroom/eine-chronische...

Artikel zum Gilead-Kauf:...